Aimei Health Technology Co., Ltd. (AFJKR)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
AFJKR Chart
Short Interest in Aimei Health Technology Co., Ltd (NASDAQ:AFJKR) Increases By 158.5%
Aimei Health Technology Co., Ltd (NASDAQ: AFJKR - Get Free Report) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,427 shares, an increase of 158.5% from the March 31st total of 552 shares. Based on an average daily volume of
Aimei Health Technology Co., Ltd. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 390,777 | $117,279.55 | $113,325.33 | -$3,954.22 | -3.37% |
Aimei Health Technology Co., Ltd. (AFJKR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Aimei Health Technology Co., Ltd. ever had a stock split?
Aimei Health Technology Co., Ltd. Profile
| Trading Companies & Distributors Industry | Industrials Sector | Junheng Xie CEO | NASDAQ (NMS) Exchange | G01341133 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Aimei Health Technology Co., Ltd., established in 2023 and headquartered in New York, New York, currently does not conduct any significant operations. The company's primary aim is to engage in a major business transaction. This could be in the form of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar business combination with one or more businesses or entities. Specifically, Aimei Health Technology is focused on identifying opportunities within the biopharmaceutical, medical technology/device, diagnostics, and other related services sectors, signaling its intention to enter and make an impact in the health technology industry.
Products and Services
Since Aimei Health Technology Co., Ltd. is in the preliminary phase of its corporate lifecycle, it has not yet developed or offered specific products or services. Its current mission revolves around exploring potential acquisitions or partnerships within various sectors of the health technology industry. The areas of interest include:
- Biopharmaceuticals: Potential future offerings could involve innovative drugs and therapeutic solutions developed through biotechnological methods, targeting unmet medical needs.
- Medical Technology/Devices: Exploring the acquisition or partnership with entities involved in the development and manufacture of advanced medical devices or technology, aimed at improving patient care and healthcare outcomes.
- Diagnostics: Interest in companies specializing in diagnostic tools and technologies, which are essential in the detection, monitoring, and management of diseases.
- Other Services: Evaluating opportunities in related service sectors which complement the core interests in biopharmaceuticals, medical technology/devices, and diagnostics. This could include healthcare IT, consulting services, and more.
